Our Team
 ♦ Founder ♦ 
 
John Wu  Ph.D. Rocky Shih  Ph.D.
•M.S. The Ohio State University
•PTS International, Inc. founder

•PTS R&D/clinical investigator
•Co-Founder
•PhD.University of Texas
•Prof. University of Texas(San Antonio)


 ♦ Management Team ♦ 

 

Lester John Wu Chairman

Mao Yuan Lin General Manager

•PTS International Inc. Chairman
•PTS ASIA Limited. Chairman
•Beijing Vision Drugs Development Limited Chairman
•Gongwin Biopharm Co.Ltd General Manager
•More than 20 years of financial operations experience in Taiwan, China, Asia Pacific
•More than 20 years of experience in biotechnology pharmaceutical industry

 

 ♦ R&D Team ♦ 

R&D Division
Charles Yang  Ph.D.
Preclinical Research Division 
Shun-Chi Wu Ph.D.

• Ph.D. National Tsing Hua Univ.
• More than 20 years of new drug development experience and cancer research. 
• Specialized in carcinogenesis


 

• Ph.D., Institute of Biochemistry and Molecular Biology, College of Medicine National Taiwan University
• > 9 yrs of experience in R&D of cancer new drugs
• Expertise in preclinical development of cancer drugs, pharmacodynamics/ pharmacokinetics /toxicology studies, new drug evaluation, projects management.

Medical Affairs Division
Eric Tu  Ph.D.
Clinical Research Division
Ben Liu Senior Manager
• Ph.D. UCSD
• > 10 yrs cancer R&D experience
• Project management

 
•M.S. UCLA/ M.P.H. Taipei Medical University 
•Rich experience in regulatory environment and operation of clinical trials in the US, China and Taiwan
•Specialized in Cancer trial planning and design

 
     

Manufacturing division
Daniel Wu Senior Manager

 
• M.S. National Taiwan Univ. 
• > 15 yrs manufacturing process
• Manufacturing process & scale-up、GMP implementation and audit
 



 ♦ Management Team ♦ 

Market Division
Pierre Xiao Vice General Manager

Administration Division
Wei Nan Hu Chief Financial Officer

•M.S. National Taiwan Univ. 
•20 years of experience in new drug development planning
•Specialized in global marketing strategy, new drug development planning
 
•M.S. National Taipei Univ. 
•15 years of accounting experience, familiar with internal control establishment
•Good at joint venture and contract related matters



 ♦ Cooperative consultant ♦ 

Michael G. Simoff  MD Zhe Ren Zhuang Ph.D.
•Henry Ford Medical Center,  Detroit, USA
•Specialties:Pulmonary Disease, Critical Care Medicine
•Services:Cancer Research, Lung and Thoracic Cancer

Ph.D. MIT
•M
ore than 20 years of experience in biotechnology pharmaceutical development
•S
pecializing in manufacturing, production development

Yi Hong Chen Ph.D. You Xiang Wang Ph.D.
•Ph.D. National Taiwan University
•Prof. China Medical University
•Specialties:Neurophysiology、Pharmacology

•Taipei Medical University Ph.D.
•Assitant Prof. Taipei Medical University
Specializing in Pharmacokinetics、Pharmacodynamics

Kai Ming Wu Dr.  Peng Fei Luo  Dr.
Taipei City Hospital 
•National Taiwan University Hospital (NTUH)
University of Otago
GUANGDONG PHARMACEUTICAL UNIVERSITY Hospital
Specializes in tumor interventional therapy, especially in the treatment of liver cancer, intestinal cancer and liver metastasis.
     
Ju Hsiang Ho
•M.S. Asian Institute of Management
•Experienced in Deloitte Taiwan
•35 years of accounting experience